Mepsevii Europska Unija - hrvatski - EMA (European Medicines Agency)

mepsevii

ultragenyx germany gmbh - vestronidase alfa - Мукополисахаридоз vii u - enzimi - mepsevii indiciran za liječenje ne neurološke manifestacije мукополисахаридоза vii (u daljnjem tekstu: zastupnici vii i mirnoj сапой sindrom).

Evkeeza Europska Unija - hrvatski - EMA (European Medicines Agency)

evkeeza

ultragenyx germany gmbh - evinacumab - hiperkolesterolemija - sredstva za modifikaciju lipida - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).